Reasons for antiretroviral switching in Colombia: A retrospective cohort study.

Sandra Liliana Valderrama-BeltránSamuel Martínez-VernazaShirley Vanessa Correa-ForeroMaria Alejandra Jaimes-ReyesLeonardo Arévalo-MoraErnesto Martínez-BuitragoJulieta FrancoClaudia Beltrán-RodríguezJuan Urrego-ReyesSebastian LeonMartha García GarzonClaudia GonzalezNorberto FonsecaMonica BoteroJavier AndradeDiana AlzamoraWilliam LenisJosé PardoJuan Alzate-ÁngelMonica MantillaOtto SussmannLeonardo Montero-RiascosCarlos Álvarez Moreno

Published in: International journal of STD & AIDS (2023)

In this Colombian cohort, drug intolerance was the main cause of the ART switch, and the time-to-switch is shorter than reports from other countries. In Colombia, it is crucial to apply current recommendations for ART initiation to choose regimens with a better tolerability profile.

Keyphrases

hiv infected
antiretroviral therapy
human immunodeficiency virus
adverse drug
hiv aids
hiv positive
hiv infected patients
open label
clinical practice
randomized controlled trial
double blind